ISRCTN20449157进行中（未招募）Unknown
Efficacy and safety of Ruyi Zhenbao tablets for patients with lumbar disc herniation: a multicenter, randomized, positive-controlled trial
Tibet Cheezheng Tibetan Medicine Co., Ltd (china)0 个研究点目标入组 400 人开始时间: 2024年8月30日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patient who meets the diagnostic criteria for lumbar disc herniation: with the guidance from the diagnostic criteria for lumbar disc herniation as outlined in the following guidelines: an evidence-based clinical guideline for the diagnosis and treatment of lumbar disc herniation with radiculopathy from the North American Spine Society (NASS, 2014), Clinical practice guideline for diagnosis and treatment of lumbar disc herniation(2020) from Chinese Orthopaedic Association of Spinal Surgery Group and Chinese Orthopaedic Association of Orthopaedic Rehabilitation Group, and the Chinese Pain Expert Consensus on the Diagnosis and Treatment of Lumbar Disc Herniation (2020). The diagnostic criteria for this study require that patients meet at least three of the first six criteria listed below, in combination with the seventh criterion (If the patient has had a CT or MRI within the past three months that provides sufficient information for a clinical diagnosis, further imaging is not required. However, if the previous imaging report is insufficient, a repeat examination is necessary). The criteria for diagnosing lumbar disc herniation are as follows:
- •1.1. Low back pain
- •1.2. Radiating pain in the lower limbs, corresponding to the distribution of the affected nerve
- •1.3. Sensory disturbances in the lower limbs, with decreased superficial sensation in the skin areas corresponding to the affected nerve
- •1.4. Positive Straight Leg Raise (SLR) test, Positive SLR enhancement test, Positive Contralateral SLR test, or Positive Femoral Nerve Stretch test
- •1.5. Diminished tendon reflexes compared to the healthy side
- •1.6. Decreased muscle strength
- •1.7 MRI or CT of the lumbar spine showing a herniated disc with nerve compression and symptoms and signs consistent with those of the involved nerve
- •2. Patients must present with symptoms of pain, numbness, or muscle tension in the lower back and/or lower limbs.
- •3. Patients must exhibit limited lumbar mobility, such as inability to bend forward, difficulty turning over in bed, or inability to sit for more than one hour.
- •4. Patient's Visual Analog Scale (VAS) score for pain: 30 mm = VAS < 70 mm
- •5. Oswestry Disability Index (ODI) Score: 20% < ODI = 80%
- •6. 18-65 years old
- •7. Patients must voluntarily agree to participate in the study and sign the informed consent form
排除标准
- •1. Patients with combined spondylolisthesis or severe nucleus pulposus protrusion causing significant cauda equina nerve compression, or substantial and progressive loss of motor function, or those with clear surgical indications who are unsuitable for conservative treatment
- •2. Patients suffering from other diseases with symptoms of lower back and leg pain, such as lumbar spinal stenosis, spondyloarthritis, ankylosing spondylitis; other possible diseases include but are not limited to osteoporosis, tumors, or herpes zoster virus infection, visceral diseases (such as pelvic inflammatory disease, appendicitis, or cholecystitis), gynecological diseases, muscle or ligament strains
- •3. Patients allergic to the study drug or with an allergic constitution, or those with contraindications to drug use
- •4. Patients with severe cardiovascular, cerebrovascular, liver, kidney diseases, or severe primary systemic diseases
- •5. Patients with mental disorders or dementia who are unable to cooperate in completing the clinical study
- •6. Pregnant or breastfeeding women
- •7. Patients who are simultaneously participating in other clinical trial studies
- •8. Patients involved in litigation or legal claims
研究者
相似试验
招募中
4 期
Clinical study of Dan Zhi Xiaoyao Tablets in the treatment of burning mouth syndrome: a randomized controlled trialBurning Mouth SyndromeITMCTR2000004110The Ninth People's Hospital affiliated to Shanghai Jiaotong University Medical College
招募中
1 期
Efficacy and safety of Wenbu Zhibi granule in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled trialITMCTR2100004482The Affiliated Jiangnan Hospital of Zhejiang Chinese Medical University
尚未招募
3 期
A clinical trial to evaluate the medicinal efficacy of Ayurvedic Tablet Bhoumya and Tablet Saathmya in COVID-19 positive Patients.CTRI/2020/06/025671Dr Giridhara Kaje
尚未招募
4 期
Efficacy, safety and economy of Zi-Long-Jin tablets in the maintenance of advanced non-small cell lung cancer (qi and blood deficiency syndrome): a multicenter, randomized, double-blind, placebo-contrnon-small cell lung cancerITMCTR1900002807The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
尚未招募
4 期
Efficacy and safety of safflower Xiaoyao tablets in the treatment of Premenstrual syndrome (liver depression and qi stagnation syndrome): a multicenter, randomized, open, positive drug parallel controlled clinical trialPMSITMCTR2200005676Peking University Third Hospital